Clinical significance of decreased or loss of ABO blood group expression in acute myeloid leukaemia: A single-centre retrospective study.
Jay Ho HanHowon LeeJae Kwon KimJaeeun YooKyuho ParkDong Wook JekarlYonggoo KimPublished in: Vox sanguinis (2024)
AML with decreased expression or loss of ABO blood group showed better early survival during D90. Transfusion support for this subgroup of AML patients should be meticulously performed considering serum typing.
Keyphrases
- acute myeloid leukemia
- poor prognosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- liver failure
- peritoneal dialysis
- bone marrow
- cardiac surgery
- prognostic factors
- binding protein
- allogeneic hematopoietic stem cell transplantation
- long non coding rna
- respiratory failure
- acute kidney injury
- clinical trial
- drug induced
- sickle cell disease
- hepatitis b virus
- acute respiratory distress syndrome
- free survival